Cross-sectional analysis shows iron overload impacts cardiac function in children with beta thalassemia, suggesting the need for regular monitoring.
Background The main factor involved in the pathophysiology of cardiac dysfunction in beta thalassemia (β-thalassemia) patients is iron overload. Aim This study aimed to detect any cardiac dysfunction or arrhythmia in clinically asymptomatic children with β-thalassemia. Patients and methods This cross-sectional study was carried out on 40 children aged from 1 to 18 years old, both sexes, with β-thalassemia major (β-TM) (group I) and 40 healthy children as a control group (group II). All patients were subjected to echocardiogram examination and 24 h ambulatory Holter device; DMS 300-3A recorder and Cardioscan CS12 software (DM software Inc., USA) 16:56. Results Serum ferritin, reticulocyte, and early to late diastolic trans mitral flow velocity ratio were significantly higher in-β-TM group than control group ( P <0.05). Minimum, maximum heart rate, duration, dispersion of P wave, R in channels 1 and 2, duration of (QRS and P–R interval), QT corrected, and high frequency domain were significantly higher in β-TM group than control group ( P <0.05). Standard deviation (SD) of normal-to-normal inter beat intervals index and root mean square of successive differences between normal heartbeats were significantly lower in β-TM group than control group ( P <0.05). The regularity of chelating therapy was significantly higher in group IB than group IA ( P <0.05). Serum ferritin was significantly higher in group IA than in group IB ( P <0.05). QT corrected was significantly higher in group IA than group IB. Conclusions Iron overload and irregularity of iron chelating therapy had a major role in cardiac affection in thalassemic patients.
No takes yet. Share an insight, caveat, or question.
Kassab et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: